Santos Marcelo Rodrigues dos, Sayegh Ana Luiza Carrari, Groehs Raphaela Vilar Ramalho, Fonseca Guilherme, Trombetta Ivani Credidio, Barretto Antônio Carlos Pereira, Arap Marco Antônio, Negrão Carlos Eduardo, Middlekauff Holly R, Alves Maria-Janieire de Nazaré Nunes
Instituto do Coração, Faculdade de Medicina, Universidade de São Paulo, BR.
Faculdade de Medicina, Universidade de São Paulo, BR.
Arq Bras Cardiol. 2015 Sep;105(3):256-64. doi: 10.5935/abc.20150078. Epub 2015 Jul 21.
Testosterone deficiency in patients with heart failure (HF) is associated with decreased exercise capacity and mortality; however, its impact on hospital readmission rate is uncertain. Furthermore, the relationship between testosterone deficiency and sympathetic activation is unknown.
We investigated the role of testosterone level on hospital readmission and mortality rates as well as sympathetic nerve activity in patients with HF.
Total testosterone (TT) and free testosterone (FT) were measured in 110 hospitalized male patients with a left ventricular ejection fraction < 45% and New York Heart Association classification IV. The patients were placed into low testosterone (LT; n = 66) and normal testosterone (NT; n = 44) groups. Hypogonadism was defined as TT < 300 ng/dL and FT < 131 pmol/L. Muscle sympathetic nerve activity (MSNA) was recorded by microneurography in a subpopulation of 27 patients.
Length of hospital stay was longer in the LT group compared to in the NT group (37 ± 4 vs. 25 ± 4 days; p = 0.008). Similarly, the cumulative hazard of readmission within 1 year was greater in the LT group compared to in the NT group (44% vs. 22%, p = 0.001). In the single-predictor analysis, TT (hazard ratio [HR], 2.77; 95% confidence interval [CI], 1.58-4.85; p = 0.02) predicted hospital readmission within 90 days. In addition, TT (HR, 4.65; 95% CI, 2.67-8.10; p = 0.009) and readmission within 90 days (HR, 3.27; 95% CI, 1.23-8.69; p = 0.02) predicted increased mortality. Neurohumoral activation, as estimated by MSNA, was significantly higher in the LT group compared to in the NT group (65 ± 3 vs. 51 ± 4 bursts/100 heart beats; p < 0.001).
These results support the concept that LT is an independent risk factor for hospital readmission within 90 days and increased mortality in patients with HF. Furthermore, increased MSNA was observed in patients with LT.
心力衰竭(HF)患者的睾酮缺乏与运动能力下降和死亡率增加有关;然而,其对住院再入院率的影响尚不确定。此外,睾酮缺乏与交感神经激活之间的关系尚不清楚。
我们研究了睾酮水平对HF患者住院再入院率、死亡率以及交感神经活动的作用。
对110例左心室射血分数<45%且纽约心脏协会心功能分级为IV级的住院男性患者测量总睾酮(TT)和游离睾酮(FT)。将患者分为低睾酮组(LT;n = 66)和正常睾酮组(NT;n = 44)。性腺功能减退定义为TT<300 ng/dL且FT<131 pmol/L。通过微神经图记录27例患者亚组的肌肉交感神经活动(MSNA)。
与NT组相比,LT组的住院时间更长(37±4天对25±4天;p = 0.008)。同样,与NT组相比,LT组1年内再入院的累积风险更高(44%对22%,p = 0.001)。在单预测因素分析中,TT(风险比[HR],2.77;95%置信区间[CI],1.58 - 4.85;p = 0.02)可预测90天内的住院再入院情况。此外,TT(HR,4.65;95%CI,2.67 - 8.10;p = 0.009)和90天内的再入院情况(HR,3.27;95%CI,1.23 - 8.69;p = 0.02)可预测死亡率增加。与NT组相比,LT组中通过MSNA估计的神经体液激活显著更高(65±3次对51±4次/100次心跳;p<0.001)。
这些结果支持以下观点,即低睾酮是HF患者90天内住院再入院和死亡率增加的独立危险因素。此外,在低睾酮患者中观察到肌肉交感神经活动增加。